Microvascular insufficiency and in turn, tissue ischemia and necrosis, contribute to a variety of chronic diseases,
and can be an adverse outcome of common reconstructive and plastic surgeries. The goal of this project is to
advance a novel ultrasound-based technology to induce neovascularization directly in vivo, and thereby enhance
local tissue perfusion. Acoustic patterning utilizes radiation forces associated with an ultrasound field to rapidly
and non-invasively organize cells or microparticles volumetrically into defined geometric assemblies. We have
shown that in vitro acoustic patterning of endothelial cells within collagen hydrogels leads to the formation of
three-dimensional microvascular networks, and that acoustic field parameters employed for patterning influence
microvessel morphology. In our recent studies, in vivo acoustic patterning of endothelial cells within injectable
hydrogels resulted in formation of perfused microvascular networks in a murine model, providing the first proof-
of-concept demonstration that non-invasive, acoustic cell patterning can be used to fabricate functional
microvascular networks directly in vivo. An important advantage of ultrasound is its ability to propagate through
tissue as an acoustic beam, thus offering avenues to rapidly translate this technology toward in vivo tissue
regeneration. Research and development in three key areas are necessary to advance acoustic patterning
towards clinical translation: i) development of systematic protocols to fabricate functional microvessel networks
within patterned hydrogels, ii) engineering innovative instrumentation for acoustic patterning in vivo, and iii)
demonstrated efficacy of the technology in a preclinical model. We address these key areas as follows. Aim 1
will identify sets of acoustic parameters, along with hydrogel and cell combinations, that give rise to functional
microvascular networks, in a manner that allows for predictable control over the morphology of three-dimensional
microvascular networks. Aim 2 will advance two acoustic instrumentation systems, a dual-transducer system
and a phase holographic lens transducer, to provide versatile systems for efficient, site-specific patterning in vivo.
Aim 3 will evaluate the efficacy of our in vivo acoustic patterning strategies using mouse models of tissue
vascularization and ischemia. Completion of this project will advance in vivo acoustic patterning technologies for
tissue vascularization to address a range of clinically relevant scenarios of tissue ischemia.
Public Health Relevance Statement
NARRATIVE
Microvascular insufficiency underlies many common, chronic diseases, including diabetic retinopathy and
neuropathy, chronic venous insufficiency and leg ulcers, cerebral infarction, and coronary microvascular disease.
Creating microvessel networks that structurally and functionally mimic the native microvasculature is critical for
a wide range of tissue engineering and regenerative medicine applications. The overall goal of this project is to
advance a novel ultrasound technology to fabricate complex, functional microvessel networks directly in vivo.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
041294109
UEI
F27KDXZMF9Y8
Project Start Date
15-May-2024
Project End Date
30-April-2028
Budget Start Date
15-May-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$510,772
Direct Costs
$334,067
Indirect Costs
$176,705
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$510,772
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01EB035523-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01EB035523-01
Patents
No Patents information available for 1R01EB035523-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01EB035523-01
Clinical Studies
No Clinical Studies information available for 1R01EB035523-01
News and More
Related News Releases
No news release information available for 1R01EB035523-01
History
No Historical information available for 1R01EB035523-01
Similar Projects
No Similar Projects information available for 1R01EB035523-01